Related Experiment Video

Updated: Aug 25, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Acute coronary syndromes: should women receive less antithrombotic medication than men?

N Danchin1

  • 1Cardiologie, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France. nicolas.danchin@egp.ap-hop-paris.fr

Heart (British Cardiac Society)
|March 17, 2004
PubMed

Insights

A meta-analysis revealed sex differences in the effectiveness and safety of glycoprotein IIb/IIIa inhibitors for acute coronary syndromes. Further research is needed to understand the underlying causes of these variations in treatment outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Glycoprotein IIb/IIIa inhibitors are crucial in managing acute coronary syndromes.
  • A recent meta-analysis indicated significant sex-based differences in their efficacy and safety.

Purpose of the Study:

  • To investigate the pathophysiological basis for observed sex differences in glycoprotein IIb/IIIa inhibitor response.
  • To determine if antithrombotic efficacy varies between sexes in different clinical scenarios.
  • To explore reasons behind the provocative findings of the meta-analysis regarding sex and treatment outcomes.

Main Methods:

  • Meta-analysis of randomized controlled trials.
  • Comparative analysis of treatment efficacy and safety data stratified by sex.
  • Exploration of potential pathophysiological and clinical factors influencing outcomes.

Main Results:

  • A significant interaction between sex and the efficacy/safety of glycoprotein IIb/IIIa agents was identified.
  • The meta-analysis highlighted potential disparities in treatment response between men and women.

Conclusions:

  • The observed sex differences warrant further investigation into underlying mechanisms.
  • Understanding these variations is critical for optimizing acute coronary syndrome treatment strategies for all patients.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...